University of North Carolina School of Medicine
Chapel Hill, North Carolina, 27599-7070, United States
NCT Number: NCT00005650
OBJECTIVES:
I. Characterize the clinical presentation of patients with primary ciliary dyskinesia.
II. Identify the genetic mutations associated with this disease.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
Chapel Hill, North Carolina, 27599-7070, United States
PROTOCOL OUTLINE:
Participants undergo a scrape biopsy acquisition of nasal cells for ciliary studies, a chest radiograph, sinus radiographs, lung function tests, sputum cultures, nitric oxide measurement, and an ear, nose and throat evaluation to screen for primary ciliary dyskinesia (PCD). Blood collection and/or a buccal scrape is also performed for genetic studies.
Genetic studies include molecular linkage analyses, genetic mapping, and gene mutation identification based on large deletions. Microsatellite markers are used to identify polymorphism.
Genetic counseling is provided to all participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00368446
Abnormalities, Multiple, Actinomycetales Infections
Bethesda, Maryland, United States
View Trial DetailsNCT05685186
Abnormalities, Multiple, Bronchial Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05161858
Abnormalities, Multiple, Bronchial Diseases
Palo Alto, California, United States
View Trial DetailsNCT06600425
Abnormalities, Multiple, Bronchial Diseases
London, United Kingdom
View Trial Details